Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medication strategies in first onset schizophrenia
NL-OMON24373Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2001
- Countries
- 1
01
Overview
Randomised, single-blind trial in schizophrenia, nonaffective psychosis and Schizophrenia Spectrum Disorders (SSD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Quality of life. Started Aug 2001; status: active, not recruiting.
02
Conditions
schizophrenianonaffective psychosisSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON24373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24373.